Zhixue Chen
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Helicobacter pylori promotes hepatocarcinogenesis by abrogating the protective effect of intestinal Bacteroides acidifaciens in females.
Journal: Journal of translational medicine
Published: February 08, 2026
Thrombotic risk trajectories in patients with coronary artery disease before and during COVID-19.
Journal: iScience
Published: August 12, 2025
Carpaine alleviates NASH-related fibrosis by targeting Nid1 to inhibit IL-6/JAK/STAT3 signaling and macrophage M1 polarization.
Journal: International journal of biological macromolecules
Published: July 29, 2025
Cancer-associated fibroblast miR-148a-5p/CALD1/collagen VI pathway promotes proliferation in Helicobacter pylori-positive gastric cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: June 23, 2025
SGMS2+ macrophages enhance NR4A3hi NK cell infiltration to improve prognosis and PD-1 treatment efficacy in hepatocellular carcinoma.
Journal: Journal of translational medicine
Published: February 22, 2025
Metabolic crosstalk between platelets and cancer: Mechanisms, functions, and therapeutic potential.
Journal: Seminars in cancer biology
Published: December 06, 2024
Liver function abnormality on admission predicts long COVID syndrome in digestive system.
Journal: Heliyon
Published: March 30, 2024
CD36-BATF2\MYB Axis Predicts Anti-PD-1 Immunotherapy Response in Gastric Cancer.
Journal: International journal of biological sciences
Published: June 30, 2023
Inactivated vaccines reduce the risk of liver function abnormality in NAFLD patients with COVID-19: a multi-center retrospective study.
Journal: EBioMedicine
Published: June 12, 2023
Advances in the conventional clinical treatment for hepatoblastoma and therapeutic innovation.
Journal: World journal of pediatric surgery
Published: October 12, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026